Cochrane · systematic review · CD004705
Biomedical risk assessment as an aid for smoking cessation
Clair, C, Mueller, Y, Livingstone‐Banks, J, et al. · Cochrane Database of Systematic Reviews · 2019 · Cochrane Library
Tobacco AddictionAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
3
current version
GRADE rated
3
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 1 · 33.3%Moderate 2 · 66.7%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Biomedical risk assessment compared with standard care or minimal intervention for smoking cessation
Population: people who smoke
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Feedback on smoking exposure Smoking cessation at longest Biomedical risk assessment vs standard care or minimal intervention | RR 1 [0.83, 1.21] | 5 studies · 2368 participants | Moderate Downgraded: risk of bias, imprecision |
Feedback on smoking‐related risk Smoking cessation at longest Biomedical risk assessment vs standard care or minimal intervention | RR 0.8 [0.63, 1.01] | 5 studies · 2064 participants | Low Downgraded: risk of bias, imprecision |
Feedback on smoking‐related harm Smoking cessation at longest Biomedical risk assessment vs standard care or minimal intervention | RR 1.26 [0.99, 1.61] | 11 studies · 3314 participants | Moderate Downgraded: risk of bias, imprecision |